Stories

What really makes cancer drug ‘super responders’ exceptional survival stories?

November 09, 2015

Reports of “super responders” – patients who do exceptionally well on a cancer treatment –may be driving unfounded assumptions about the effectiveness of the drugs involved, researchers caution. “People who tell these stories should be more forthright ...

What really makes cancer drug ‘super responders’ exceptional survival stories?

November 09, 2015

Reports of “super responders” – patients who do exceptionally well on a cancer treatment –may be driving unfounded assumptions about the effectiveness of the drugs involved, researchers caution.

Kidney cancer’s genomic drivers revealed

November 04, 2015

A massive search involving cancer researchers across the U.S. and Canada has revealed many of the altered genes and cell signaling pathways that drive a poorly understood form of kidney cancer, primary papillary renal cell carcinoma. The findings, ...

Kidney cancer’s genomic drivers revealed

November 04, 2015

A massive search involving cancer researchers across the U.S. and Canada has revealed many of the altered genes and cell signaling pathways that drive a poorly understood form of kidney cancer, primary papillary renal cell carcinoma.

Bay Area Cancer Center first to join OHSU Knight Cancer Network

October 31, 2015

Bay Area Hospital and the OHSU Knight Cancer Institute have agreed to launch the first site of the newly formed OHSU Knight Cancer Network at the Bay Area Cancer Center in Coos Bay, Oregon. The two institutions signed a letter of intent to determine ...

Media’s frequent use of superlative terms to describe new cancer drugs questioned by study

October 29, 2015

An analysis of media coverage published in JAMA Oncology finds that the use of superlative terms to describe new cancer drugs is commonplace even when the drugs show only modest benefits or there is still a lack of clinical data to support ...

Media’s frequent use of superlative terms to describe new cancer drugs questioned by study

October 29, 2015

An analysis of media coverage published in JAMA Oncology finds that the use of superlative terms to describe new cancer drugs is commonplace even when the drugs show only modest benefits or there is still a lack of clinical data to support enthusiastic statements.

OHSU releases Mole Mapper ResearchKit app to track potential skin cancers

October 14, 2015

Oregon Health & Science University today released an iPhone app designed to advance melanoma research by giving users the ability to accurately measure and monitor moles, and contribute photos of how their potential trouble spots evolve over time. ...

Immunovia, OHSU collaborating on early detection test for pancreatic cancer

October 04, 2015

Immunovia AB and the Knight Cancer Institute at Oregon Health & Science University (OHSU) formed a collaboration to confirm, validate and commercialize a blood test for the early diagnosis of pancreatic cancer. The test called IMMray™ PanCan-d ...

OHSU hosts event to thank Knight Cancer Challenge supporters

June 30, 2015

Media Alert What Knight Cancer Challenge Community Celebration When 11:30 a.m. to 1 p.m., Wednesday, July 1. Program beings at 12:15 p.m. Where Pioneer Courthouse Square, 701 S.W. 6th Avenue, Portland, Oregon, 97204 Details Speakers will include OHSU ...

Stories

OHSU in the News